HaemaLogiX opens enrollment for the phase 1 KOALA trial of KMCAR T-cell therapy in relapsed or refractory kappa-restricted multiple...
Lire la suiteNovo Nordisk has presented new OASIS 4 sub-analyses at ECO2026, showing strong weight loss and mobility improvements from oral...
Lire la suiteUCB has expanded its strategic alliance with Cancer Research UK and Cancer Research Horizons to accelerate novel oncology candidates....
Lire la suiteMyomaker Bio, a Loughborough University spin-out, has launched a world-first lab-grown human muscle platform for drug developers. Boehringer Ingelheim...
Lire la suiteMSK researchers have reported encouraging long-term follow-up results from a small phase 1 trial of a personalised mRNA vaccine...
Lire la suiteTransgene has completed patient randomisation in the phase 2 part of its phase 1/2 TG4050 trial in head and...
Lire la suite